Índice

• • ·Shooting for the moon, and the stars?

    Página :1019

     
• • ·Hypofractionation for prostate cancer: tested and proven

    Página :1020-1022

    W Robert Lee

     
• • ·The case for informative phase 2 trials in osteosarcoma

    Página :1022-1023

    Katherine A Janeway, Richard Gorlick

     
• • ·Obinutuzumab plus bendamustine in rituximab-refractory indolent lymphoma

    Página :1023-1025

    Paul A Hamlin

     
• • ·Radiotherapy to intervention sites in mesothelioma: no more?

    Página :1025-1027

    Giovanni Luca Ceresoli, Vittorio Vavassori

     
• • ·Reducing radiation doses for breast tomosynthesis?

    Página :1027-1029

    Martin J Yaffe

     
• • ·Combined modality adjuvant therapy for high-risk endometrial cancer

    Página :1029-1030

    Adriaan Vanderstichele, Patrick Neven, Ignace Vergote

     
• • ·Early treatment for high-risk smouldering myeloma: has the time come?

    Página :1030-1032

    Heinz Ludwig

     
• • ·A prognostically relevant miRNA signature for epithelial ovarian cancer

    Página :1032-1033

    Daniel W Cramer, Kevin M Elias

     
• • ·Combination chemotherapy for relapsed small-cell lung cancer

    Página :1033-1035

    Gregory P Kalemkerian

     
• • ·The mastectomy myth

    Página :1035-1037

    Beryl McCormick

     
• • ·Progression-free survival landmark analysis: a critical endpoint in melanoma clinical trials

    Página :1037-1039

    Paolo A Ascierto, Georgina V Long

     
• • ·Timing of androgen-deprivation therapy for prostate cancer: still a long way to go

    Página :e313

    Nicola Fossati, Giorgio Gandaglia, Paolo Dell’Oglio, Francesco Montorsi, Alberto Briganti

    
• • ·Timing of androgen-deprivation therapy for prostate cancer: still a long way to go – Authors’ reply

    Página :e313

    Gillian M Duchesne

    
• • ·Salvage radiotherapy for patients with rising PSA

    Página :e314

    Nicola Fossati, Cesare Cozzarini, Claudio Fiorino, Giorgio Gandaglia, Francesco Montorsi, Alberto Briganti

    
• • ·Salvage radiotherapy for patients with rising PSA – Authors’ reply

    Página :e315

    Christian Carrie, Sophie Dussart

    
• • ·Quality of life after video-assisted surgery for lung cancer

    Página :e315

    Reza J Mehran, Jack A Roth

    
• • ·Quality of life after video-assisted surgery for lung cancer

    Página :e316

    Giulia Veronesi, Pierluigi Novellis, Bernard Park

    
• • ·Quality of life after video-assisted surgery for lung cancer

    Página :e317

    
• • ·Quality of life after video-assisted surgery for lung cancer

    Página :e318

    Seshiru Nakazawa, Kimihiro Shimizu, Toshiteru Nagashima, Akira Mogi, Hiroyuki Kuwano

    
• • ·Quality of life after video-assisted surgery for lung cancer – Author’s reply

    Página :e318

    Peter Bjørn Licht, Claus Andersen, Ole Dan Jørgensen, Morten Bendixen

    
• • ·Venetoclax in cancer therapy and potential effects on bone

    Página :e319

    Farasat Zaman, Per Kogner, Lars Sävendahl

    
• • ·Correction to Lancet Oncol 2015; 16: 733

    Página :e321

    
• • ·Correction to Lancet Oncol 2016; 17:1055

    Página :e321

    
• • ·Correction to Lancet Oncol 2016; 17: 1163, 1165

    Página :e321

    
• • ·ESMO World Congress on Gastrointestinal Cancer 2016

    Página :1040

    Robert Carlson

    Esquema Esquema  
• • ·Using PET–CT to tailor treatment for Hodgkin’s lymphoma

    Página :e322

    Sanjay Tanday

     
• • ·Tasquinimod treatment for prostate cancer

    Página :e322

    Vicki Brower

    
• • ·Progression-free survival with regorafenib in gastric cancer

    Página :e323

    Talha Khan Burki

     
• • ·Transoral robotic surgery for oropharyngeal cancer

    Página :e323

    Judith A Gilbert

    
• • ·Pembrolizumab for classical Hodgkin’s lymphoma

    Página :e324

    Talha Khan Burki

     
• • ·BRCA mutations and risk of uterine cancer

    Página :e324

    Sanjay Tanday

    
• • ·Targeting PADI2 could stop the progression of myeloma

    Página :e325

    Sanjay Tanday

     
• • ·Attitudes and practices towards legal euthanasia

    Página :e325

    Talha Khan Burki

    
• • ·High frequency of gene mutations in metastatic prostate cancer

    Página :e326

    Emma Wilkinson

     
• • ·Bendamustine combined regimen for Hodgkin’s lymphoma

    Página :e326

    Priya Venkatesan

    
• • ·Adaptive treatments show promise in breast cancer

    Página :e327

    Holly Baker

     
• • ·A Woman Like Me

    Página :1041

    Caroline Anne Kinsey

     
• • ·When cancer gets gnarly

    Página :1042

    Abigail Grace Murdy

     
• • ·Reconstruction through fragmentation

    Página :1043

    Kelley Swain

     
• • ·Embroidered Cancer Comic

    Página :1044

    Jessica Short

     
• • ·Beauty After Breast Cancer

    Página :1044

    Victoria Denny

     
• • ·Boy meets girl, girl gets cancer

    Página :1045

    Abigail Grace Murdy

     
• • ·The C Word

    Página :1046

    Jocalyn Clark

     
• • ·Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

    Página :1047-1060

    David Dearnaley, Isabel Syndikus, Helen Mossop, Vincent Khoo, Alison Birtle, David Bloomfield, John Graham, Peter Kirkbride, John Logue, Zafar Malik, Julian Money-Kyrle, Joe M O’Sullivan, Miguel Panades, Chris Parker, Helen Patterson, Christopher Scrase, John Staffurth, Andrew Stockdale, Jean Tremlett, Margaret Bidmead, Helen Mayles, Olivia Naismith, Chris South, Annie Gao, Clare Cruickshank, Shama Hassan, Julia Pugh, Clare Griffin, Emma Hall, CHHiP Investigators

    Resumen Resumen Esquema Esquema   
• • ·Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial

    Página :1061-1069

    Luca Incrocci, Ruud C Wortel, Wendimagegn Ghidey Alemayehu, Shafak Aluwini, Erik Schimmel, Stijn Krol, Peter-Paul van der Toorn, Hanja de Jager, Wilma Heemsbergen, Ben Heijmen, Floris Pos

    Resumen Resumen Esquema Esquema   
• • ·Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial

    Página :1070-1080

    Sophie Piperno-Neumann, Marie-Cécile Le Deley, Françoise Rédini, Hélène Pacquement, Perrine Marec-Bérard, Philippe Petit, Hervé Brisse, Cyril Lervat, Jean-Claude Gentet, Natacha Entz-Werlé, Antoine Italiano, Nadège Corradini, Emmanuelle Bompas, Nicolas Penel, Marie-Dominique Tabone, Anne Gomez-Brouchet, Jean-Marc Guinebretière, Eric Mascard, François Gouin, Aurélie Chevance, Naïma Bonnet, Jean-Yves Blay, Laurence Brugières, Sarcoma Group of UNICANCER, French Society of Pediatric Oncology (SFCE), French Sarcoma Group (GSF-GETO)

    Resumen Resumen Esquema Esquema   
• • ·Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

    Página :1081-1093

    Laurie H Sehn, Neil Chua, Jiri Mayer, Gregg Dueck, Marek Trn?ný, Kamal Bouabdallah, Nathan Fowler, Vincent Delwail, Oliver Press, Gilles Salles, John Gribben, Anne Lennard, Pieternella J Lugtenburg, Natalie Dimier, Elisabeth Wassner-Fritsch, Günter Fingerle-Rowson, Bruce D Cheson

    Resumen Resumen Esquema Esquema   
• • ·Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial

    Página :1094-1104

    Amelia O Clive, Hazel Taylor, Lee Dobson, Paula Wilson, Emma de Winton, Niki Panakis, Justin Pepperell, Timothy Howell, Samuel A Stewart, Erika Penz, Nikki Jordan, Anna J Morley, Natalie Zahan-Evans, Sarah Smith, Timothy J P Batchelor, Adrian Marchbank, Lesley Bishop, Alina A Ionescu, Mike Bayne, Samantha Cooper, Anthony Kerry, Peter Jenkins, Elizabeth Toy, Vallipuram Vigneswaran, James Gildersleve, Merina Ahmed, Fiona McDonald, Mick Button, Conrad Lewanski, Charles Comins, Muthukumar Dakshinamoorthy, Y C Gary Lee, Najib M Rahman, Nick A Maskell

    Resumen Resumen Esquema Esquema   
• • ·Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study

    Página :1105-1113

    Daniela Bernardi, Petra Macaskill, Marco Pellegrini, Marvi Valentini, Carmine Fantò, Livio Ostillio, Paolina Tuttobene, Andrea Luparia, Nehmat Houssami

    Resumen Resumen Esquema Esquema   
• • ·Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

    Página :1114-1126

    Stephanie M de Boer, Melanie E Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Meder, Petronella B Ottevanger, Jonathan A Ledermann, Pearly Khaw, Alessandro Colombo, Anthony Fyles, Marie-Helene Baron, Henry C Kitchener, Hans W Nijman, Roy F Kruitwagen, Remi A Nout, Karen W Verhoeven-Adema, Vincent T Smit, Hein Putter, Carien L Creutzberg, PORTEC study group †

    Resumen Resumen Esquema Esquema   
• • ·Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial

    Página :1127-1136

    María-Victoria Mateos, Miguel-Teodoro Hernández, Pilar Giraldo, Javier de la Rubia, Felipe de Arriba, Lucía López Corral, Laura Rosiñol, Bruno Paiva, Luis Palomera, Joan Bargay, Albert Oriol, Felipe Prosper, Javier López, José-María Arguiñano, Nuria Quintana, José-Luis García, Joan Bladé, Juan-José Lahuerta, Jesús-F San Miguel

    Resumen Resumen Esquema Esquema   
• • ·Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study

    Página :1137-1146

    Marina Bagnoli, Silvana Canevari, Daniela Califano, Simona Losito, Massimo Di Maio, Francesco Raspagliesi, Maria Luisa Carcangiu, Giuseppe Toffoli, Erika Cecchin, Roberto Sorio, Vincenzo Canzonieri, Daniela Russo, Giosué Scognamiglio, Gennaro Chiappetta, Gustavo Baldassarre, Domenica Lorusso, Giovanni Scambia, Gian Franco Zannoni, Antonella Savarese, Mariantonia Carosi, Paolo Scollo, Enrico Breda, Viviana Murgia, Francesco Perrone, Sandro Pignata, Loris De Cecco, Delia Mezzanzanica, Multicentre Italian Trials in Ovarian cancer (MITO) translational group

    Resumen Resumen Esquema Esquema   
• • ·Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial

    Página :1147-1157

    Koichi Goto, Yuichiro Ohe, Taro Shibata, Takashi Seto, Toshiaki Takahashi, Kazuhiko Nakagawa, Hiroshi Tanaka, Koji Takeda, Makoto Nishio, Kiyoshi Mori, Miyako Satouchi, Toyoaki Hida, Naruo Yoshimura, Toshiyuki Kozuki, Fumio Imamura, Katsuyuki Kiura, Hiroaki Okamoto, Toshiyuki Sawa, Tomohide Tamura, JCOG0605 investigators

    Resumen Resumen Esquema Esquema   
• • ·10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study

    Página :1158-1170

    Marissa C van Maaren, Linda de Munck, Geertruida H de Bock, Jan J Jobsen, Thijs van Dalen, Sabine C Linn, Philip Poortmans, Luc J A Strobbe, Sabine Siesling

    Resumen Resumen Esquema Esquema   
• • ·International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Página :e328

    Shaji Kumar, Bruno Paiva, Kenneth C Anderson, Brian Durie, Ola Landgren, Philippe Moreau, Nikhil Munshi, Sagar Lonial, Joan Bladé, Maria-Victoria Mateos, Meletios Dimopoulos, Efstathios Kastritis, Mario Boccadoro, Robert Orlowski, Hartmut Goldschmidt, Andrew Spencer, Jian Hou, Wee Joo Chng, Saad Z Usmani, Elena Zamagni, Kazuyuki Shimizu, Sundar Jagannath, Hans E Johnsen, Evangelos Terpos, Anthony Reiman, Robert A Kyle, Pieter Sonneveld, Paul G Richardson, Philip McCarthy, Heinz Ludwig, Wenming Chen, Michele Cavo, Jean-Luc Harousseau, Suzanne Lentzsch, Jens Hillengass, Antonio Palumbo, Alberto Orfao, S Vincent Rajkumar, Jesus San Miguel, Herve Avet-Loiseau

    Resumen Resumen Esquema Esquema  
• • ·Novel therapeutic targets on the horizon for lung cancer

    Página :e347

    Wan-Ling Tan, Amit Jain, Angela Takano, Evan W Newell, N Gopalakrishna Iyer, Wan-Teck Lim, Eng-Huat Tan, Weiwei Zhai, Axel M Hillmer, Wai-Leong Tam, Daniel S W Tan

    Resumen Resumen Esquema Esquema  
• • ·Brazilian health-care policy for targeted oncology therapies and companion diagnostic testing

    Página :e363

    Carlos Gil Ferreira, Maria Isabel Achatz, Patricia Ashton-Prolla, Maria Dirlei Begnami, Fabricio K Marchini, Stephen Doral Stefani

    Resumen Resumen Esquema Esquema